SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-23-293493
Filing Date
2023-12-12
Accepted
2023-12-12 17:00:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C d844837dsc14d9c.htm SC14D9C 15791
2 EX-99.1 d844837dex991.htm EX-99.1 14671
3 EX-99.2 d844837dex992.htm EX-99.2 119727
4 GRAPHIC g844837g1213020146065.jpg GRAPHIC 3393
  Complete submission text file 0001193125-23-293493.txt   156572
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filed by) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-92771 | Film No.: 231481904
SIC: 2836 Biological Products, (No Diagnostic Substances)